Loading clinical trials...
Loading clinical trials...
This is a prospective data collection of treatment outcome for newly diagnosed oligometastatic breast cancers with 1-3 bone metastases. Eligible patients will be identified from the weekly Breast MDC....
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
King Hussein Cancer Center
NCT05941299 · Mastectomy, Segmental, Breast Neoplasm Malignant Female
NCT04198727 · Breast Neoplasm Malignant Female
NCT03109080 · Breast Neoplasms, Triple-Negative, Breast Neoplasm Malignant Female, and more
King Hussein Cancer Center
Amman
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions